Particular aspects of adverse event assessment in post marketing surveillance

被引:3
作者
Baier, D [1 ]
机构
[1] Hoffmann La Roche Ag, D-79630 Grenzach Wyhlen, Germany
关键词
post-marketing surveillance; research design; bias; confounding factors; effect modifiers; observational study; moclobemide;
D O I
10.1016/S0924-9338(98)80142-9
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
The main feature of observational studies is the representation of naturalistic treatment conditions. In contrast to clinical trials, they allow the evaluation and quantification of adverse event profiles of drugs under "real life" conditions. The price for this unquestionable chance is the proneness to distorting factors, which may aggravate the interpretation of the study results. Analysis of observational study results therefore has to control for potentially influential factors and reconsider possible alternatives explaining observed associations. The most important distorting factors, which should be tal;cn into account during analysis and interpretation are under-reporting, event selection, bias, confounding and misusage? Authors and readers of such study results should be aware of this possible sources of error, in order to derive optimal benefit from this study approach. (C) 1998 Elsevier, Paris.
引用
收藏
页码:164 / 170
页数:7
相关论文
共 23 条
[1]  
Baier D, 1997, FOCUS DEPRESS ANX, V8, P29
[2]  
BORDEN EK, 1984, CLIN RES PROCESS PHA, P337
[3]   HYPERTENSION WITH MOCLOBEMIDE [J].
BOYD, IW .
LANCET, 1995, 346 (8988) :1498-1498
[4]  
CHEN DT, 1993, CLIN NEUROPHARMACOL, V16, pS63
[5]   HYPERTENSION WITH MOCLOBEMIDE [J].
COULTER, DM ;
PILLANS, PI .
LANCET, 1995, 346 (8981) :1032-1032
[6]  
Feighner JP, 1995, J CLIN PSYCHIAT, V56, P574
[7]  
GIESCHKE R, 1998, J NEURAL TRANSM, V26, P97
[8]  
GRIFFIN JP, 1991, THERAPIEWOCHE, V41, P2244
[9]   Epidemiology and relative toxicity of antidepressant drugs in overdose [J].
Henry, JA .
DRUG SAFETY, 1997, 16 (06) :374-390
[10]  
HETZEL W, 1983, RIMA ANTIDEPRESSIVEN, P49